Visit us at Medica, Dusseldorf, Germany 17-20 November 2025 at Hall 16, Stand D17-5 and ask us about our free AI tools and the document builder.
Pure Global

ANTISTREPTOLYSIN - ANVISA Registration 10377390325

Access comprehensive regulatory information for ANTISTREPTOLYSIN in Brazil's medical device market through Pure Global AI's free database. This Risk Class II medical device is registered under ANVISA number 10377390325 and manufactured by KATAL BIOTECNOLOGICA INDÚSTRIA E COMÉRCIO LTDA. The registration is held by KATAL BIOTECNOLOGICA INDUSTRIA E COMERCIO LTDA with validity until currently active (VIGENTE).

This page provides complete technical specifications for this device, regulatory compliance details, 5 companies making the same product including BIOSYSTEMS S.A., KOVALENT DO BRASIL LTDA, and 5 recent registrations in the same technical category. Pure Global AI offers free access to over 100,000+ Brazilian medical device registrations, helping global MedTech companies navigate ANVISA regulations, identify competitors, and discover partnership opportunities efficiently.

Free Database
Powered by Pure Global AI
100,000+ Devices
5 Competitors
5 Recent Registrations
10377390325
Registration Details
ANVISA Registration Number: 10377390325
DJ Fang

DJ Fang

MedTech Regulatory Expert

Need help with 30+ markets registration?

Pricing
Free consultation

Device Details

Família Antiestreptolisina O (ASLO)
Risk Class II

Registration Details

10377390325

25351066357202568

71437917000104

Company Information

Brazil
PT: BRASIL

Dates and Status

Jun 09, 2025

VIGENTE

09/18/2025 19:00:01